Detailed instructions for taking the lung cancer targeted drug crizotinib and precautions

Crizotinib, often sold under the trade name Xalkori, is a targeted therapy forALK-positive or ROS1-positive advanced non-small cell lung cancer (NSCLC). For lung cancer patients who are being treated with this drug, it is crucial to understand the correct way to take the drug and related precautions.

The recommended dosage of crizotinib is 250 mg twice daily. Patients should take it at regular times in the morning and evening, and the capsules should be swallowed whole and should not be chewed, dissolved or opened. This drug can be taken with food or alone, but avoid consuming it with grapefruit juice or pomelo, as they may affect the metabolism of crizotinib in the body.

While taking crizotinib, lung cancer patients should pay attention to the following key points:

1. Strictly follow the doctor’s instructions: Be sure to use the medicine accurately according to the doctor’s instructions, and do not increase or decrease the dose on your own. If you miss a dose and it is less than 6 hours before the next dose, you do not need to take it again. You can just wait for the next normal dose. If you vomit after taking the medicine, there is no need to take another dose and wait for the next time to take the medicine.

2. Regular medical examination: Go to the hospital regularly for necessary examinations such as liver and kidney function, blood routine and electrocardiogram to ensure that the side effects of drugs on the body are under control.

3. Pay attention to adverse reactions: Crizotinib may cause side effects such as visual impairment, nausea, diarrhea and vomiting. If you experience symptoms such as blurred vision, photophobia, floaters, or vision loss, seek medical help immediately. At the same time, timely medical treatment is also required for severe reactions such as fever, chills, sudden shortness of breath accompanied by cough or fever.

4. Avoid high-risk activities: Because the drug may cause vision problems and fatigue, patients should avoid driving or operating machinery and other activities that require high concentration and clear vision while taking the drug.

5. Medication for special patient groups: Special patients with hepatic insufficiency, renal insufficiency, and pregnant women should be particularly careful when using crizotinib, and adjust the dosage as directed by the doctor.

6. Be aware of drug interactions: Always consult your doctor before using other medications (including over-the-counter medications, vitamins, and herbal medicines) at the same time to avoid potential drug interactions.

In summary, although crizotinib provides an effective treatment option for lung cancer patients, patients still need to strictly follow medical instructions and various precautions during medication to ensure the safety and effectiveness of the medication. During the treatment period, maintaining good communication with the doctor and promptly reporting the medication status and any discomfort reactions are the keys to helping the doctor adjust the treatment plan and achieve the best treatment effect.